Breeding Capital is once again offering investors access to an unusual asset class, bloodstock.
The firm has launched fundraising for its Breeding Capital II and III ventures, aiming to deliver high medium-term returns to shareholders with a portfolio of broodmares, foals and yearlings.
Breeding Capital will selectively build up its portfolio of broodmares, sourced both nationally and internationally, estimated to cost on average around £500,000.
Under the Enterprise Investment Scheme, investors are able to obtain:
- 20% upfront tax relief (£400,000 per annum maximum per investor)
- Capital gains free of tax
- Reinvestment relief – gains currently taxable at 40% likely to be taxable at 18% in 2012
- Income tax loss relief
- Inheritance tax relief, once the shares have been held for two years
Breeding Capital managing director William Sporborg says the alternative asset class has shown strong growth over the last decade.
“Our proven team not only has over 100 years experience in the bloodstock and investment industry but has worked successfully together on the original Breeding Capital (in 2006),” he says.
“These innovative and tax efficient new companies are a great opportunity for individuals to invest in a portfolio of quality bloodstock. We see the bloodstock industry as a non–correlated, niche, alternative asset class which should form part of an investor’s investment portfolio."
To comment on this story, contact:
0207 034 2681
Two global vehicles
'Further plug advice gap'
Must appoint separate CEOs and boards
Advisers do come out well
Will report to Mark Till